Equity Analysis /
United States of America

US : Teva Pharmaceutical Industries Ltd. - TEVA | Weekly Rx Metrics: Key Product Declines Across the Board Following Strong Highs Last Week

    Michael Parolari
    Michael Parolari

    Research Associate

    CGS-CIMB
    28 March 2022
    Published by